HOXD12 | Homeobox D12 | Predicted intracellular proteins Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/59444/134367_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
HRASLS2 | HRAS-like suppressor 2 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58997/140141_A_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
HSD17B2 | Hydroxysteroid (17-beta) dehydrogenase 2 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50235/145600_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/22775/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22770/90919_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
HTR3E | 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic | Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49764/121567_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/40591/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40591/116271_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
IL17REL | Interleukin 17 receptor E-like | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images/45546/ihc_cell_selected_60x60.jpg) | ![](/images/45546/102877_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
INSM1 | Insulinoma-associated 1 | Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ISL1 | ISL LIM homeobox 1 | Predicted intracellular proteins Transcription factors
| ![](/images/57416/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/57416/132767_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
ITLN1 | Intelectin 1 (galactofuranose binding) | Plasma proteins Predicted secreted proteins
| ![](/images/12652/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/63275/143068_A_1_7_selected_60x60.jpg) | ![](/images/63275/142655_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes Predicted intracellular proteins
| ![](/images/40454/144748_B_8_7_selected_60x60.jpg) | ![](/images/40454/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40454/144750_A_5_1_rna_selected_60x60.jpg) | Tissue enhanced |
KCNH6 | Potassium voltage-gated channel, subfamily H (eag-related), member 6 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images/22674/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22674/50804_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
KCNK10 | Potassium channel, subfamily K, member 10 | Predicted membrane proteins
| ![](/images/30462/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30462/64781_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
KLK15 | Kallikrein-related peptidase 15 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| ![](/images/19802/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19802/47764_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
KRT12 | Keratin 12 | Disease related genes Plasma proteins Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KRT20 | Keratin 20 | Plasma proteins Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/32/1899_B_2_7_rna_selected_60x60.jpg) | Tissue enhanced |
KRT8 | Keratin 8 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1696/4749_A_1_5_rna_selected_60x60.jpg) | Tissue enhanced |
LBX2 | Ladybird homeobox 2 | Predicted intracellular proteins Transcription factors
| | ![](/images/44257/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/44257/104062_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
LCN15 | Lipocalin 15 | Predicted secreted proteins
| ![](/images/60584/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60584/135625_B_3_5_rna_selected_60x60.jpg) | Tissue enhanced |
LGALS9B | Lectin, galactoside-binding, soluble, 9B | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47218/116820_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
LGALS9C | Lectin, galactoside-binding, soluble, 9C | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47218/116820_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
LIME1 | Lck interacting transmembrane adaptor 1 | Predicted secreted proteins
| ![](/images/15363/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15363/36296_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
LIPH | Lipase, member H | Disease related genes Predicted intracellular proteins Predicted secreted proteins
| ![](/images/49079/ihc_selected_60x60.jpg) | ![](/images/49079/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/49079/112554_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
LMX1A | LIM homeobox transcription factor 1, alpha | Predicted intracellular proteins Transcription factors
| ![](/images/30088/ihc_selected_60x60.jpg) | ![](/images/28051/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/30088/67290_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
LRAT | Lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| ![](/images/8397/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8397/25135_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
LRRC31 | Leucine rich repeat containing 31 | Predicted intracellular proteins
| ![](/images/37548/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37548/78925_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
LRRC66 | Leucine rich repeat containing 66 | Predicted membrane proteins
| ![](/images/14549/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14549/39353_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
LRRC75A | Leucine rich repeat containing 75A | Predicted intracellular proteins
| | ![](/images/28528/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/28528/61263_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
LYPD2 | LY6/PLAUR domain containing 2 | Predicted secreted proteins
| ![](/images/28599/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28599/59310_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
MARCH4 | Membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase | Predicted membrane proteins
| ![](/images/14348/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14348/34996_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
MARVELD3 | MARVEL domain containing 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/43514/ihc_selected_60x60.jpg) | ![](/images/43514/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/43514/94914_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
MBOAT4 | Membrane bound O-acyltransferase domain containing 4 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MFSD4 | Major facilitator superfamily domain containing 4 | Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MIA2 | Melanoma inhibitory activity 2 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54066/128120_A_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
MINOS1-NBL1 | MINOS1-NBL1 readthrough | Predicted secreted proteins
| ![](/images/7394/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/59930/133195_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
MISP | Mitotic spindle positioning | Cytoskeleton related proteins Predicted intracellular proteins
| | | | ![](/images/49511/148884_B_3_4_rna_selected_60x60.jpg) | Tissue enhanced |
MLPH | Melanophilin | Disease related genes Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/14685/57496_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13/156692_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
MMEL1 | Membrane metallo-endopeptidase-like 1 | Enzymes Predicted intracellular proteins
| ![](/images/8205/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8205/23017_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
MNX1 | Motor neuron and pancreas homeobox 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MT1B | Metallothionein 1B | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MT1HL1 | Metallothionein 1H-like 1 | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MTRNR2L8 | MT-RNR2-like 8 | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/36/155173_B_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
MUC3A | Mucin 3A, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| ![](/images/10871/ihc_selected_60x60.jpg) | ![](/images/10871/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/10871/27290_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
MYB | V-myb avian myeloblastosis viral oncogene homolog | Cancer-related genes Predicted intracellular proteins Transcription factors
| ![](/images/17704/ihc_selected_60x60.jpg) | ![](/images/17704/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17704/40999_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
MYEOV | Myeloma overexpressed | Predicted membrane proteins
| ![](/images/12949/ihc_selected_60x60.jpg) | ![](/images/12949/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/12949/29762_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
MYO7B | Myosin VIIB | Cytoskeleton related proteins Predicted intracellular proteins
| ![](/images/39131/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39131/81447_B_5_3_rna_selected_60x60.jpg) | Tissue enhanced |
MYRF | Myelin regulatory factor | Enzymes Plasma proteins Predicted membrane proteins Transcription factors
| ![](/images/18310/ihc_selected_60x60.jpg) | ![](/images/18310/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/18310/41992_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |